Scarica l'app Stockscreener
102.60
1.66%
1.68
Pre-mercato:
103.68
1.08
+1.05%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Incyte Corp Borsa (INCY) Ultime notizie
Incyte’s Transition From A Jakafi Company To A More Diversified Pharma - Citeline News & Insights
A Glimpse Into The Expert Outlook On Incyte Through 8 Analysts - Benzinga
Barclays Maintains Overweight Rating on INCY, Raises Price Targe - GuruFocus
TD Cowen Keeps Buy Rating on Incyte (INCY), Cites Roadmap to Triple Non-Jakafi Revenue by 2029 - Finviz
Incyte (INCY) Reports Next Week: Wall Street Expects Earnings Growth - Finviz
Prelude climbs as FDA clears study for Incyte-partnered cancer candidate - Seeking Alpha
Analysts Differ in Opinion on Jakafi Drug Maker Incyte (INCY) - Finviz
Incyte (INCY) to Release Earnings on Tuesday - MarketBeat
Value Investing Opportunity: Incyte Corp. (NASDAQ:INCY) Presents a Compelling Case - Chartmill
Incyte (INCY) Gains European Recommendation for Zynyz Therapy - GuruFocus
Incyte (INCY) Gains EMA Panel Support for Expanded Use of Zynyz - GuruFocus
Incyte wins EU backing for MacroGenics-partnered cancer drug in GIT indication - Seeking Alpha
Incyte gets positive CHMP opinion for anal cancer drug Zynyz - StreetInsider
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC) - Yahoo Finance
Ruffer LLP Has $3.74 Million Holdings in Incyte Corporation $INCY - MarketBeat
Undercovered Dozen: Incyte, Annaly Capital, ImmunityBio And More - Seeking Alpha
Incyte to Report Fourth Quarter and Year-End 2025 Financial Results - Chartmill
INCY Stock Price and Chart — NASDAQ:INCY - TradingView
Here's Why Incyte (INCY) is a Strong Momentum Stock - Yahoo Finance
Incyte Corporation $INCY Stock Position Lowered by Mitsubishi UFJ Trust & Banking Corp - MarketBeat
Why Incyte (INCY) is a Top Value Stock for the Long-Term - Yahoo Finance
Incyte Corporation $INCY Stock Position Raised by Massachusetts Financial Services Co. MA - MarketBeat
Engaging In Insider Activity, Patrick Mayes At Incyte Exercises Options Worth $0 - Benzinga
Thomas Tray Decides To Exercise Options At Incyte Worth $0 - Benzinga
Engaging In Insider Activity, Matteo Trotta At Incyte Exercises Options Worth $0 - Benzinga
Breaking Update: PABLO CAGNONI Engages In Options Exercise At Incyte Realizing $0 - Benzinga
Steven Stein Decides To Exercise Options At Incyte Worth $0 - Benzinga
What Investors Should Know Before Buying Incyte Stock (NASDAQ:INCY) - Seeking Alpha
Incyte Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains - 富途牛牛
Reassessing Incyte (INCY) Valuation After Wells Fargo’s Neutral Downgrade - Yahoo Finance
Wells Fargo & Company Downgrades Incyte (NASDAQ:INCY) to Hold - MarketBeat
Sun Pharma settles litigation with Incyte Corp over hair loss drug Leqselvi - MSN
Incyte (INCY) Faces Downgrade and Adjusted Price Target by Wells Fargo - GuruFocus
Incyte (INCY) Faces Downgrade with Revised Price Target by Wells Fargo | INCY Stock News - GuruFocus
IBM To Rally Around 8%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
Wells Fargo downgrades Incyte stock to Equal Weight as upgrade thesis plays out - Investing.com
New Incyte Drug Combo Shows Power Against Deadly Lymphoma - mychesco.com
EC approves label expansion of INCY's lymphoma drug Minjuvi - MSN
Why Incyte (INCY) Stock Is Trading Up Today - Finviz
Is Incyte (INCY) Still Attractively Priced After Its Strong 1 Year Share Price Gain? - Yahoo Finance
Incyte (INCY) Receives Updated Buy Rating from TD Cowen | INCY S - GuruFocus
Incyte (NASDAQ:INCY) Given New $128.00 Price Target at TD Cowen - MarketBeat
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Earnings Preview: What To Expect From Incyte's Report - Barchart.com
GRIMES & Co WEALTH MANAGEMENT LLC Sells 16,883 Shares of Incyte Corporation $INCY - MarketBeat
Lobbying Update: $70,000 of INCYTE CORPORATION lobbying was just disclosed - Quiver Quantitative
Will Incyte (INCY) Beat Estimates Again in Its Next Earnings Report? - Finviz
Incyte Corporation (INCY) Stock Analysis: Strong Revenue Growth and Strategic Developments in the Biotech Sector - DirectorsTalk Interviews
Incyte Corp. stock underperforms Monday when compared to competitors - MSN
ImmunityBio, Xencor Drugs Win E.U. Nods - Los Angeles Business Journal
INCY's phase III Monjuvi study meets key goals in first-line lymphoma - MSN
What margin trends mean for Incyte Corporation stockOil Prices & High Return Trade Guides - Улправда
Incyte Corporation $INCY Stock Holdings Increased by Cerity Partners LLC - MarketBeat
Will Incyte Corporation (ICY) stock beat value stocks2025 Analyst Calls & Smart Investment Allocation Tips - ulpravda.ru
Incyte Corporation Stock Live Price, Chart, Analysis, News & Forecast – Buy, Sell & Trade US Equities Today - livemint.com
Incyte Corporation (INCY) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Incyte jumps amid takeover speculation - MSN
Bull of the Day: Eli Lilly (LLY) - Finviz
This Biotech Stock Eyes Fresh Entry With 522% Earnings Growth Seen - Investor's Business Daily
Can Incyte Corporation stock reach $100 price targetExit Point & Scalable Portfolio Growth Methods - ulpravda.ru
3.42%
1.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):